Device Trial Radar · NCT07572331
Clinical Study Evaluating the Safety and Effectiveness of the NIRA Laser M2.1 for the Treatment of Full-Face Wrinkles
Last checked: Nov 20, 2026Latest source record: May 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120
Actual
Start
Jan 13, 2025
Primary completion
Oct 21, 2025
Study completion Oct 21, 2025
Sponsor
- Lead sponsor
- NIRA Innovations Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 7, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 35 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical trial evaluated the safety and effectiveness of the NIRA Laser M2.1, with or without a topical treatment, for the treatment of full-face wrinkles in adults. Participants were assigned to one of two treatment arms: laser-only treatment or laser treatment followed by topical treatment. Wrinkle improvement was assessed using standardized facial photographs reviewed by blinded evaluators, and participant satisfaction and safety observations were also assessed.
Conditions
- Skin Ageing
- Facial Wrinkles
- Acne
- Skin Elasticity
- Infraorbital Dark Circle Severity
- Skin Firmness
- UV Spots
- Skin Texture
- Skin Pores
- Brown Spots
- Porphyrins
- Red Spots
Interventions
NIRA Laser M2.1Device
Hand-held OTC 1450nm diode laser device for full-face wrinkle treatment. Subjects treated themselves privately in their own homes, daily, per the Instructions for Use.
TopicalOther
Topical skincare formulation designed for twice daily, full-face application. Used in Arm 2 only in addition to the NIRA Laser M2.1.
Primary outcomes
What the sponsor says the trial is designed to measure.
- ARM 1 and ARM 2: Full Face Wrinkle Effectiveness Primary Endpoint a)Time frame: 28 weeks
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Northeast Dermatology Associates
Beverly, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.